Affiliation:
1. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
Abstract
ABSTRACT
Genome sequencing has demonstrated that
Staphylococcus aureus
encodes arginine biosynthetic genes
argDCJBFGH
synthesizing proteins that mediate arginine biosynthesis using glutamate as a substrate. Paradoxically, however,
S. aureus
does not grow in a defined, glutamate-replete medium lacking arginine and glucose (CDM-R). Studies from our laboratory have found that specific mutations are selected by
S. aureus
that facilitate growth in CDM-R. However, these selected mutants synthesize arginine utilizing proline as a substrate rather than glutamate. In this study, we demonstrate that the ectopic expression of the
argDCJB
operon supports the growth of
S. aureus
in CDM-R, thus documenting the functionality of this pathway. Furthermore, suppressor mutants of
S. aureus
JE2
putA::Tn,
which is defective in synthesizing arginine from proline, were selected on CDM-R agar. Genome sequencing revealed that these mutants had compensatory mutations within both
spoVG
, encoding an ortholog of the
Bacillus subtilis
stage V sporulation protein, and
sarA,
encoding the staphylococcal accessory regulator. Transcriptional studies document that
argD
expression is significantly increased when JE2
spoVG sarA
was grown in CDM-R. Lastly, we found that a mutation in
ahrC
was required to induce
argD
expression in JE2
spoVG sarA
when grown in an arginine-replete medium (CDM), suggesting that AhrC also functions to repress
argDCJB
in an arginine-dependent manner. In conclusion, these data indicate that the
argDCJB
operon is functional when transcribed
in vitro
and that SNPs within potential putative regulatory proteins are required to alleviate the repression.
IMPORTANCE
Although
Staphylococcus aureus
has the capability to synthesize all 20 amino acids, it is phenotypically auxotrophic for several amino acids including arginine. This work identifies putative regulatory proteins, including SpoVG, SarA, and AhrC, that function to inhibit the arginine biosynthetic pathways using glutamate as a substrate. Understanding the ultimate mechanisms of why
S. aureus
is selected to repress arginine biosynthetic pathways even in the absence of arginine will add to the growing body of work assessing the interactions between metabolism and
S. aureus
pathogenesis.
Funder
HHS | NIH | National Institute of Allergy and Infectious Diseases
American Heart Association
Publisher
American Society for Microbiology